학술논문

The L730V/I RET roof mutations display different activities toward pralsetinib and selpercatinib
Document Type
Article
Source
In: npj Precision Oncology. (npj Precision Oncology, December 2021, 5(1))
Subject
Language
English
ISSN
2397768X